We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+26.9%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$34.9M
Cap. Flow
+$7.29M
Cap. Flow %
3.61%
Top 10 Hldgs %
43.02%
Holding
86
New
26
Increased
16
Reduced
19
Closed
17

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$10.7M
2
AET
Aetna Inc
AET
+$6.28M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.94M
4
CAH icon
Cardinal Health
CAH
+$2.36M
5
JUNO
Juno Therapeutics, Inc.
JUNO
+$2.14M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$7.07M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.48M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.09M
4
ELV icon
Elevance Health
ELV
+$2.88M
5
MZOR
Mazor Robotics Ltd.
MZOR
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 66.28%
2 Financials 3.15%
3 Energy 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
51
CALL
DELISTED
Medicines Co
MDCO
$1.22M 0.6%
+25,000
New +$1.14M
DPLO
52
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.2M 0.59%
75,000
+25,000
+50% +$361K
PACB icon
53
Pacific Biosciences
PACB
$357M
$1.11M 0.55%
215,000
+65,000
+43% +$318K
ELGX
54
DELISTED
Endologix Inc
ELGX
$1.09M 0.54%
+15,000
New +$992K
RARX
55
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.06M 0.53%
50,000
– –
ZYNE
56
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1M 0.5%
+50,000
New +$994K
VTRS icon
57
CALL
Viatris
VTRS
$18.7B
$975K 0.48%
+25,000
New +$1.01M
IMMU
58
CALL
DELISTED
Immunomedics Inc
IMMU
$971K 0.48%
+150,000
New +$760K
TBPH icon
59
Theravance Biopharma
TBPH
$877M
$921K 0.46%
+25,000
New +$799K
SCYX icon
60
SCYNEXIS
SCYX
$48.4M
$828K 0.41%
3,750
+625
+20% +$157K
NERV icon
61
Minerva Neurosciences
NERV
$208M
$810K 0.4%
12,500
-6,250
-33% -$485K
SGMO
62
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$780K 0.39%
+150,000
New +$602K
AUPH icon
63
Aurinia Pharmaceuticals
AUPH
$2.05B
$551K 0.27%
+75,000
New +$346K
AGTC
64
DELISTED
Applied Genetic Technologies Corporation
AGTC
$518K 0.26%
+75,000
New +$586K
NVCN
65
DELISTED
Neovasc Inc.
NVCN
$505K 0.25%
+13
New +$493K
ADMA icon
66
ADMA Biologics
ADMA
$2.19B
$488K 0.24%
100,000
– –
OMED
67
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$461K 0.23%
50,000
– –
OBSV
68
DELISTED
ObsEva SA Ordinary Shares
OBSV
$260K 0.13%
+25,000
New +$307K
TNDM icon
69
Tandem Diabetes Care
TNDM
$1.64B
$120K 0.06%
10,000
+2,500
+33% +$54.7K
ADAP
70
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-100,000
Closed -$405K
AXDX
71
DELISTED
Accelerate Diagnostics
AXDX
– –
-3,000
Closed -$623K
AZN icon
72
CALL
AstraZeneca
AZN
$247B
– –
-25,000
Closed -$1.37M
BSX icon
73
Boston Scientific
BSX
$74.5B
– –
-65,000
Closed -$1.41M
CI icon
74
CALL
Cigna
CI
$72B
– –
-25,000
Closed -$3.33M
DXCM icon
75
DexCom
DXCM
$33.6B
– –
-80,000
Closed -$1.19M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2017 Portfolio in Review

As of Q1 2017, Iguana Healthcare Management held 86 positions worth $202M, up 21% from $167M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $7.29M of net new capital in Q1 2017, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was Shire pic: 61,250 shares worth $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 76% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Biogen, an estimated $7.07M trimmed.

  • Iguana Healthcare Management's largest Q1 2017 buy was Shire pic: 61,250 shares worth $10.7M.
  • Iguana Healthcare Management added most to Celgene Corp in Q1 2017, an estimated $1.2M increase.
  • Iguana Healthcare Management's biggest Q1 2017 reduction was Biogen, cutting an estimated $7.07M.
  • Iguana Healthcare Management fully exited Elevance Health in Q1 2017, selling an estimated $2.88M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $202M portfolio in Q1 2017.
  • Iguana Healthcare Management opened 26 new positions and closed 17 in Q1 2017.
  • Iguana Healthcare Management's portfolio value rose 21% quarter-over-quarter to $202M.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.